Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin and ethinylestradiol combination versus monotherapy in women with polycystic ovary syndrome
IRCT20260926071196N1Phase 2Recruiting
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-blind trial of metformin, ethinyl estradiol and desogestrel in polycystic ovary syndrome (PCOS) (3 arms), sponsored by Tabriz University of Medical Sciences. Primary endpoints: Hormonal outcomes and Clinical outcomes. Started Oct 2026; status: recruiting.
02
Drugs
metforminethinyl estradioldesogestrel
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on IRCT20260926071196N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260926071196N1.